Filed: 2/14/2023ACC: 0001214659-23-002234
📋 What this filing means
TCG CROSSOVER MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 21 equity positions with a total reported market value of $566.61M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
21
Positions
$566.61M
Total AUM (reported)
49.16M
Total Shares
Allocation by class
COMM$534.51M94.3%
ADRS$32.10M5.7%
Portfolio Concentration
Top 3$235.65M41.6%
4–10$215.06M38.0%
11–25$115.90M20.5%
Top 3 weight
41.6%
Top 10 weight
79.5%
Voting Authority Distribution
Total shares with voting rights: 49.16M
Sole
Full voting authority
49.16M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole21
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings21
Rows:
IVERIC BIO INC
SOLEShares5.14M
TypeSH
Market value$110.07M
19.43%
Sole
5.14M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares288.05K
TypeSH
Market value$83.61M
14.76%
Sole
288.05K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares3.63M
TypeSH
Market value$41.97M
7.41%
Sole
3.63M
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares5.91M
TypeSH
Market value$37.03M
6.53%
Sole
5.91M
Shared
0.00
None
0.00
GERON CORP
SOLEShares15.19M
TypeSH
Market value$36.75M
6.49%
Sole
15.19M
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares2.10M
TypeSH
Market value$32.10M
5.67%
Sole
2.10M
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares1.08M
TypeSH
Market value$31.68M
5.59%
Sole
1.08M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS, INC
SOLEShares983.61K
TypeSH
Market value$28.73M
5.07%
Sole
983.61K
Shared
0.00
None
0.00
VENTYX BIOSCIENCES, INC
SOLEShares787.23K
TypeSH
Market value$25.81M
4.56%
Sole
787.23K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS, INC
SOLEShares3.40M
TypeSH
Market value$22.95M
4.05%
Sole
3.40M
Shared
0.00
None
0.00
VECTIVBIO HOLDING AG
SOLEShares2.33M
TypeSH
Market value$20.22M
3.57%
Sole
2.33M
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares1.14M
TypeSH
Market value$18.03M
3.18%
Sole
1.14M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares1.42M
TypeSH
Market value$17.67M
3.12%
Sole
1.42M
Shared
0.00
None
0.00
IMMUNOVANT, INC
SOLEShares854.85K
TypeSH
Market value$15.17M
2.68%
Sole
854.85K
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares1.99M
TypeSH
Market value$15.12M
2.67%
Sole
1.99M
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares1M
TypeSH
Market value$10.50M
1.85%
Sole
1M
Shared
0.00
None
0.00
ENTRADA THERAPEUTICS INC
SOLEShares584.96K
TypeSH
Market value$7.91M
1.40%
Sole
584.96K
Shared
0.00
None
0.00
MERUS BV
SOLEShares300K
TypeSH
Market value$4.64M
0.82%
Sole
300K
Shared
0.00
None
0.00
CABALETTA BIO, INC
SOLEShares486.80K
TypeSH
Market value$4.50M
0.79%
Sole
486.80K
Shared
0.00
None
0.00
ALPINE IMMUNE SCIENCES INC
SOLEShares253.07K
TypeSH
Market value$1.86M
0.33%
Sole
253.07K
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares288.39K
TypeSH
Market value$274.0K
0.05%
Sole
288.39K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
IVERIC BIO INCSOLE | COMM | 5.14M | SH | $110.07M 19.43% | 5.14M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COMM | 288.05K | SH | $83.61M 14.76% | 288.05K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COMM | 3.63M | SH | $41.97M 7.41% | 3.63M | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COMM | 5.91M | SH | $37.03M 6.53% | 5.91M | 0.00 | 0.00 |
GERON CORPSOLE | COMM | 15.19M | SH | $36.75M 6.49% | 15.19M | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADRS | 2.10M | SH | $32.10M 5.67% | 2.10M | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COMM | 1.08M | SH | $31.68M 5.59% | 1.08M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS, INCSOLE | COMM | 983.61K | SH | $28.73M 5.07% | 983.61K | 0.00 | 0.00 |
VENTYX BIOSCIENCES, INCSOLE | COMM | 787.23K | SH | $25.81M 4.56% | 787.23K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS, INCSOLE | COMM | 3.40M | SH | $22.95M 4.05% | 3.40M | 0.00 | 0.00 |
VECTIVBIO HOLDING AGSOLE | COMM | 2.33M | SH | $20.22M 3.57% | 2.33M | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COMM | 1.14M | SH | $18.03M 3.18% | 1.14M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COMM | 1.42M | SH | $17.67M 3.12% | 1.42M | 0.00 | 0.00 |
IMMUNOVANT, INCSOLE | COMM | 854.85K | SH | $15.17M 2.68% | 854.85K | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COMM | 1.99M | SH | $15.12M 2.67% | 1.99M | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | COMM | 1M | SH | $10.50M 1.85% | 1M | 0.00 | 0.00 |
ENTRADA THERAPEUTICS INCSOLE | COMM | 584.96K | SH | $7.91M 1.40% | 584.96K | 0.00 | 0.00 |
MERUS BVSOLE | COMM | 300K | SH | $4.64M 0.82% | 300K | 0.00 | 0.00 |
CABALETTA BIO, INCSOLE | COMM | 486.80K | SH | $4.50M 0.79% | 486.80K | 0.00 | 0.00 |
ALPINE IMMUNE SCIENCES INCSOLE | COMM | 253.07K | SH | $1.86M 0.33% | 253.07K | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COMM | 288.39K | SH | $274.0K 0.05% | 288.39K | 0.00 | 0.00 |